SE8901149D0 - Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat - Google Patents

Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat

Info

Publication number
SE8901149D0
SE8901149D0 SE8901149A SE8901149A SE8901149D0 SE 8901149 D0 SE8901149 D0 SE 8901149D0 SE 8901149 A SE8901149 A SE 8901149A SE 8901149 A SE8901149 A SE 8901149A SE 8901149 D0 SE8901149 D0 SE 8901149D0
Authority
SE
Sweden
Prior art keywords
cholecystokinin
pupill
oegat
agents
construction
Prior art date
Application number
SE8901149A
Other languages
English (en)
Swedish (sv)
Inventor
A Bill
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8901149A priority Critical patent/SE8901149D0/xx
Publication of SE8901149D0 publication Critical patent/SE8901149D0/xx
Priority to JP2506058A priority patent/JPH03505224A/ja
Priority to CA002030525A priority patent/CA2030525A1/en
Priority to PCT/SE1990/000219 priority patent/WO1990011773A1/en
Priority to AU54282/90A priority patent/AU627570B2/en
Priority to EP90906391A priority patent/EP0422181A1/en
Priority to HU903583A priority patent/HU206185B/hu
Priority to EP19920113164 priority patent/EP0522596A1/en
Priority to NO90905069A priority patent/NO905069L/no
Priority to KR1019900702506A priority patent/KR920700044A/ko
Priority to FI905952A priority patent/FI905952A0/fi
Priority to SU904894239A priority patent/RU2003331C1/ru
Priority to BG093398A priority patent/BG93398A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8901149A 1989-04-03 1989-04-03 Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat SE8901149D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8901149A SE8901149D0 (sv) 1989-04-03 1989-04-03 Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
EP19920113164 EP0522596A1 (en) 1989-04-03 1990-04-03 Method and means for inducing constriction of the pupil in the eye
AU54282/90A AU627570B2 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
CA002030525A CA2030525A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
PCT/SE1990/000219 WO1990011773A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
JP2506058A JPH03505224A (ja) 1989-04-03 1990-04-03 眼の瞳孔の収縮をそれぞれ誘起または防止するための方法および手段
EP90906391A EP0422181A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
HU903583A HU206185B (en) 1989-04-03 1990-04-03 Process for producing pharmaceutical compositions suitable for causing or hindering pupillary contraction
NO90905069A NO905069L (no) 1989-04-03 1990-11-22 Fremgangsmaate og middel for indusering, resp. forhindringav forsnevring av pupillen i oeyet.
KR1019900702506A KR920700044A (ko) 1989-04-03 1990-11-23 눈의 동공수축을 유도 및 방지하기 위한 방법 및 수단
FI905952A FI905952A0 (fi) 1989-04-03 1990-12-03 Foerfarande och medel foer inducering eller foerhindrande av sammandragning av pupillen i oegat.
SU904894239A RU2003331C1 (ru) 1989-04-03 1990-12-03 Средство дл регулировани сокращени глазного зрачка
BG093398A BG93398A (bg) 1989-04-03 1990-12-06 Метод и средство за индуциране и съответно предотвратяване свиване зеницата на окото

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901149A SE8901149D0 (sv) 1989-04-03 1989-04-03 Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat

Publications (1)

Publication Number Publication Date
SE8901149D0 true SE8901149D0 (sv) 1989-04-03

Family

ID=20375526

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901149A SE8901149D0 (sv) 1989-04-03 1989-04-03 Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat

Country Status (10)

Country Link
EP (1) EP0422181A1 (bg)
JP (1) JPH03505224A (bg)
KR (1) KR920700044A (bg)
AU (1) AU627570B2 (bg)
BG (1) BG93398A (bg)
CA (1) CA2030525A1 (bg)
FI (1) FI905952A0 (bg)
HU (1) HU206185B (bg)
SE (1) SE8901149D0 (bg)
WO (1) WO1990011773A1 (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206237A (en) * 1991-05-14 1993-04-27 Merck & Co., Inc. Benzodiazepine analogs
US5185331A (en) * 1991-05-14 1993-02-09 Merck & Co., Inc. Triazolobenzodiazepines
US5210082A (en) * 1991-05-16 1993-05-11 Merck & Co., Inc. 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder
US5177071A (en) * 1991-06-17 1993-01-05 Merck & Co., Inc. 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder
SE9201425D0 (sv) * 1992-05-06 1992-05-06 Kabi Pharmacia Ab Method and means for preventing constriction of the pupil in the eye

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400377A (en) * 1980-09-26 1983-08-23 Farmitalia Carlo Erba, S.P.A. Use of polypeptides as analgesic drugs
DK489683A (da) * 1982-10-27 1984-04-28 Amano Pharma Co Ltd Fremgangsmaade til fremstilling af peptider
IT1179866B (it) * 1984-12-12 1987-09-16 Rotta Research Lab Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
IT1179894B (it) * 1984-12-27 1987-09-16 Rotta Research Lab Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
IT1204430B (it) * 1986-01-10 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
DD272653A1 (de) * 1987-02-09 1989-10-18 Akad Wissenschaften Ddr Verfahren zur herstellung neuer antagonisten des cholecystokinins

Also Published As

Publication number Publication date
AU627570B2 (en) 1992-08-27
HUT55994A (en) 1991-07-29
FI905952A0 (fi) 1990-12-03
WO1990011773A1 (en) 1990-10-18
KR920700044A (ko) 1992-02-19
HU903583D0 (en) 1991-05-28
CA2030525A1 (en) 1990-10-04
HU206185B (en) 1992-09-28
JPH03505224A (ja) 1991-11-14
EP0422181A1 (en) 1991-04-17
AU5428290A (en) 1990-11-05
BG93398A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
EA199900811A1 (ru) Композиция для офтальмологических хирургических операций (варианты) и способ их осуществления
CY1109827T1 (el) Χρηση της αλλαντοτοξινης για την αγωγη δυσκολα αντιμετωπισιμης δυσλειτουργιας κενωσης
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
BR0213738A (pt) proteìnas morfogênicas ósseas (bmp), receptores de bmp e proteìnas de ligação de bmp e seu uso no diagnóstico e no tratamento de glaucoma
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
KR920019342A (ko) 골질환 치료제
AR024233A1 (es) Compuestos moduladores de ccr5, composiciones farmaceuticas, su uso en medicina.
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
ES2187719T3 (es) Derivados difluoroprostaglandinas y su aplicacion.
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
MX9203667A (es) Sales de bis-dimetoximetil (trimetoxibencil)quinolino, su preparacion y composicines farmaceuticas que las contienen.
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
EA199900499A1 (ru) Фармацевтическая композиция, включающая соединение, обладающее анти-xa активностью, и соединение антагонист агрегации тромбоцитов
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR9907715A (pt) Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose
SE8901149D0 (sv) Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
BR9712308A (pt) Inibidor de catarata secundária
EE200100188A (et) Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
SE9201425D0 (sv) Method and means for preventing constriction of the pupil in the eye
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.